PHI with Non-Melanoma Skin Cancer (Basal Cell Carcinoma/Squamous Cell Carcinoma)
How does this condition affect your private health insurance?
Weißer Hautkrebs, or non-melanoma skin cancer, primarily encompasses Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). These are the most common cancers, typically appearing on sun-exposed skin. BCC often presents as a pearly bump or non-healing sore, while SCC may look like a red, scaly patch or firm nodule. Both grow slowly and rarely metastasize, but can cause local tissue damage if left untreated. Early detection and surgical removal are key to a high cure rate. Risk factors include chronic UV exposure and fair skin. Though rarely life-threatening, treatment can lead to scarring and requires ongoing surveillance for new lesions.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Months to several years before detection and treatment.
Duration of Illness (Lifetime)
One-time event for a specific lesion, but chronic risk of new occurrences or recurrences over a lifetime.
Cost of Treatment (Initial)
Typically moderate (e.g., hundreds to several thousands of dollars for surgical removal), depending on size, location, and treatment method.
Cost of Treatment (Lifetime)
Potentially significant over a lifetime due to the risk of multiple occurrences and follow-up care, ranging from several thousands to tens of thousands of dollars.
Mortality Rate
Very low (<0.1% for BCC, 0.2-5% for SCC, primarily in advanced or aggressive cases).
Risk of Secondary Damages
Moderate, including local tissue destruction, scarring, disfigurement if untreated or in complex cases; psychological impact from diagnosis and treatment.
Probability of Full Recovery
Very high (95-99% for BCC, 90-95% for SCC with timely and appropriate treatment).
Underlying Disease Risk
Low for direct underlying diseases, but often associated with chronic sun damage, fair skin type, immunosuppression, and genetic predispositions.